Posaconazol Devatis 100 mg, magensaftresistente Tablette - 24 Swissmedic Key 69323001 Registration Holder Devatis AG Name Posaconazol Devatis 100 mg, magensaftresistente Tablette Date of registration 08.05.2024 Original/Generic Generic Introduction of Sequence 08.05.2024 ATC-Classification Posaconazole (J02AC04) Revision date WHO WHO-DDD Valid until 07.05.2029 Index Therapeuticus (BSV) 08.06. Show package size 24 Index Therapeuticus (Swissmedic) 08.06. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 481.04 Limitation Yes Limitation text
Deductible 10 % Consumer price 544.50 Feedback FB Daily cost GTIN 7680693230019 Medication Code Synthetika Pharmacode Disponibility
Composition posaconazolum 100 mg, hypromellosi acetas succinas, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 2.25 mg, silica colloidalis anhydrica, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, E 172 (flavum), pro compresso. Packungsbestandteile Galenic Form Gastric juice resistant tablets Active Agent Dose Posaconazole 100 mg
BAG: Active Agent Dose Posaconazole 100 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hydroxypropylcellulosum Hypromellosi Acetas Succinas Macrogol 4000 Magnesii Stearas Poly(Alcohol Vinylicus) Überzug Pro Compresso Silica Colloidalis Anhydrica Talcum
Source Data was imported : 07.06.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
